Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Mologic
Mologic
Activities:
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Regulatory
Mologic’s COVID-19 self-test selected for RADx initiative funding
The initiative was launched by the US National Institutes of Health to accelerate the development, commercialisation and implementation of technologies for COVID-19 testing
Finance
Avacta and Mologic announce commercial partnership
Clinical evaluation of the lateral flow test is currently being carried out at a hospital in mainland Europe and Avacta will shortly initiate further clinical validation studies in the UK and abroad
Research & Development
Mologic launches rapid diagnostic test for fungal crop pathogen Botrytis
The company developed and trialled BotrytisAlert with Berry Garden Growers, NIAB EMR and the Warwickshire College
Research & Development
Mologic completes new ultra-sensitive rapid diagnostic test
The next phase of development will include setting up local manufacturing facilities in areas with need of the device for preventing the spread of epidemics
Pharmaceutical
Mologic expands US and UK operations
The UK-based company that develops lateral flow and rapid diagnostic technologies has made multiple appointments in order to bolster US presence
Subscribe now